Warburg Pincus Takes Over Integrace in Rs 1,200 Crore Deal, True North and Temasek Exit Written By Parthika Patel17 July 2026 4:50 PM ISTMumbai: Global private equity firm Warburg Pincus has acquired Mumbai-based pharmaceutical company Integrace Private Limited in a deal valued at...
Zydus Wins GST Appeal, Rs 41.9 Lakh Demand Reduced to Rs 0.44 Lakh Written By Parthika Patel14 Jun 2026 6:34 PM ISTAhmedabad: Zydus Lifesciences Limited has informed stock exchanges that its wholly owned subsidiary, Zydus Healthcare Limited (ZHL), has received...
Zydus Healthcare Asked to Revise Phase IV Protocol for Empagliflozin-Metformin Tablets Written By Susmita Roy5 April 2026 11:00 AM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has asked for revisions in the Phase IV...
India's Semaglutide Market Set for Generic Boom as Patents Expire, Over 50 Brands Lined Up for Launch, See Full List Written By Farhat Nasim4 March 2026 10:15 PM ISTNew Delhi: The expiry of semaglutide's key patent in India in March 2026 is ushering in a tsunami of generic versions of the blockbuster diabetes and...
CDSCO Flags 63 Drug Batches Including Paracetamol, Dexona as Not of Standard Quality in October Written By Susmita Roy23 Nov 2025 8:07 PM ISTNew Delhi: In a striking reminder of the ongoing challenges in India's pharmaceutical quality ecosystem, 63 batches of widely used medicines have been...
CDSCO Flags 112 Drug Batches Including Telmisartan, Pantoprazole, Cefixime, Glimepiride as Not of Standard Quality Written By Susmita Roy25 Oct 2025 1:53 PM ISTNew Delhi: The Central Drugs Standard Control Organization (CDSCO) has identified 112 batches of medicines and medical products as "Not of Standard...
Zydus Gets CDSCO Panel Nod to Market Sodium Chloride Nebuliser Solution Written By Parthika Patel7 Oct 2025 6:21 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has recommended granting permission to...
Zydus Secures CDSCO Panel Go-Ahead For Phase III Trial of Empagliflozin-Metoprolol FDC Parthika Patel22 July 2025 6:19 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Cardiovascular division of the Central Drugs Standard Control Organisation (CDSCO) has...
Zydus Gets SEC Nod to Begin Phase IV Trial of Dydrogesterone ER for Habitual Miscarriage Parthika Patel15 July 2025 8:21 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Reproductive division of the Central Drugs Standard Control Organisation (CDSCO) has granted...
NPPA fixes retail prices of 71 formulations including Empagliflozin, Metformin, Sitagliptin and Glimepiride Written By Ruchika Sharma8 July 2025 5:45 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices of 71 formulations under Drugs (Prices Control) Order,...
Gufic Biosciences appoints Rajesh Kaul as Senior President - Sparsh Cluster Written By Ruchika Sharma3 July 2025 12:39 PM ISTGujarat: Gufic Biosciences has announced the appointment of Rajesh Kaul as Senior President - Sparsh Cluster, Senior Management Personnel of the...
Zydus Gets CDSCO Panel Nod to Conduct Phase IV Trial for Indacaterol-Budesonide FDC Inhalation Written By Dr. Divya Colin20 Jun 2025 11:45 PM ISTNew Delhi: In response to the proposal presented by Zydus Healthcare, the Subject Expert Committee (SEC) functional under the Central Drug Standard...
